Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2019-08-01
2020-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gait-based Evaluation of Early Rehabilitation After ACL Reconstruction
NCT05481918
Gait Rehabilitation Following an Anterior Cruciate Ligament Reconstruction
NCT02930239
Exercise Program for Knee Recovery in Football Players with ACL Injuries
NCT06808763
The Effect of Various Strength Training Protocols in ACL Reconstructed Participants
NCT03364647
Knee vs. Ankle Training on Knee Mechanics After ACLR
NCT05241795
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The experimental group participants (approximately 20 participants) will receive, a standard graduated return-to-run program, a 4-week lower-extremity exercise program, and an activity log to track exercise progress. Participants will be instructed to follow-up with their research physical therapist once a week for the first 4 weeks and then every other week until the run progression is completed. During follow-ups experimental group participants will receive gait retraining cues to transition to a NRFS running pattern.
Therapeutic Intervention
Instruction for all participants in the experimental group will begin with transitioning foot strike pattern from a rearfoot strike to a non-rearfoot strike running pattern (NRFS) and increasing preferred step rate by 5-10%. Each participant program thereafter will be progressed individually according to the clinical investigators follow up assessments of running mechanics and participant pain and function with running. Intervention gait retraining sessions will include drills for reinforcement to include soft landing single leg bounding, adequate time to practice, and pre-class and post-class video assessment with feedback.
Control Group
The control group participants (approximately 20 participants) will receive, a standard graduated return-to-run program, a 4-week lower-extremity exercise program, and an activity log to track exercise progress. Participants will be instructed to follow-up with their research physical therapist once a week for the first 4 weeks and then every other week until the run progression is completed. During follow-ups control group participants will not receive any gait retraining cues and will only be instructed on standard of care return to run metrics to include volume, load, and duration of running.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Therapeutic Intervention
Instruction for all participants in the experimental group will begin with transitioning foot strike pattern from a rearfoot strike to a non-rearfoot strike running pattern (NRFS) and increasing preferred step rate by 5-10%. Each participant program thereafter will be progressed individually according to the clinical investigators follow up assessments of running mechanics and participant pain and function with running. Intervention gait retraining sessions will include drills for reinforcement to include soft landing single leg bounding, adequate time to practice, and pre-class and post-class video assessment with feedback.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Between 18-50 years of age
3. Active duty Soldier or cadet
4. History of Anterior Cruciate Ligament Reconstruction in the last 18 months
5. Cleared to return to run by their Department of Defense medical provider (primary care physician, orthopedic surgeon, physical therapist, or athletic trainer)
6. Ability to perform 20 unassisted single leg heel raises bilaterally
7. Ability to perform 10 pain-free, symmetrical, single-leg squats to between 45-60 degrees bilaterally
8. Ability to perform 20 pain-free single leg hops in place bilaterally
Exclusion Criteria
2. Concomitant Posterior Cruciate Ligament or Lateral Cruciate Ligament injury
3. Concomitant meniscectomy \>50%
4. History of inflammatory arthritis or gout
5. History of ACL injury to either knee
6. History of major lower-extremity joint injury and/or surgery
7. Known pregnancy currently or in the previous 6 months
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Telemedicine & Advanced Technology Research Center
OTHER
Keller Army Community Hospital
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie Morris
Director & Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erin M Miller, MS, ABD
Role: PRINCIPAL_INVESTIGATOR
Keller Army Community Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keller Army Community Hospital
West Point, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19KACH001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.